Message Automation in the Press Message Automation's domain experts are frequently quoted in industry publications. In the last few months these have included The Banker, Banking Technology, SWIFT Dialogue Magazine, Investor Services Journal, Wall Street & Technology, IBS Journal and others. As these are subscription publications, copyright prevents us from re-publishing these articles here. October 2007: Message Automation and City Networks launch Proactive Derivatives At SIBOS 2007, Message Automation and City Networks officially launched Proactive Derivatives, a comprehensive solution for automating post-trade management of OTC derivatives. Full story from Finextra July 2007: City Networks to make strategic investment in OTC derivatives specialist Message Automation City Networks announced today their intention to invest in Message Automation, the London-based derivatives processing specialist. The two companies have agreed terms for City Networks to acquire a significant minority stake in Message Automation. At the same time, both companies have signed a partnership agreement that enables City Networks to add extensive derivatives processing to their business solutions. Under this new partnership agreement, City Networks will be able to offer their 500+ global customers Message Automation's matching and reconciliation technology, which is based on FpML (Financial products Markup Language), the industry standard protocol for OTC derivatives products. Full story from Bob's Guide Commenting on the alliance, Hugh Daly, CEO of Message Automation said, "Our proven capabilities in the derivatives market provide a natural fit with City Networks' established and global customer base. The investment will allow us to grow our business to meet the demand we are encountering in the market. For many organisations, the OTC Derivatives post trade problem is a long way from being fixed and this is a powerful alliance which will go a long way to resolving this problem". October 2006: Message Automation announces first comprehensive STP solution for OTC derivatives Details in the press release.